November 18, 2011

NACDS and NCPA announced that they have sent joint letters to the Joint Select Committee on Deficit Reduction and the U.S. Senate Armed Services Committee, encouraging the rejection of an Obama administration proposal that would “saddle Tricare beneficiaries with higher prices and penalize their utilization of community pharmacists.”

November 18, 2011

Par Pharmaceutical has completed its acquisition of Anchen Pharmaceuticals, the generic drug maker said.

November 17, 2011

Drug maker Eli Lilly is donating more than $4 million to the Infectious Disease Research Institute, the company said Thursday.

November 17, 2011

The increase in the number of people with rheumatoid arthritis, and the challenges posed to drug makers by generics, is encouraging the development of new drugs for the disease, according to a new report by Frost & Sullivan.

November 16, 2011

When its blockbuster cholesterol drug Lipitor loses patent protection this month, Pfizer is hoping that pharmacy benefit managers will not dispense a generic version of the drug to its customers, according to published reports.

November 15, 2011

Actavis has launched an authorized generic drug for treating pain, the company said.

November 15, 2011

German drug maker Boehringer Ingelheim Pharmaceuticals invested more than $350 million in its U.S. operations this year, the company said Tuesday.

November 15, 2011

The generic drug lobby is stepping up its efforts to persuade the congressional super committee to avoid adopting rules that would ban some patent settlements between branded and generic drug makers.

November 11, 2011

Watson Pharmaceuticals is challenging Swiss drug maker Novartis' patent on a drug used to treat dementia, Watson said.

November 9, 2011

Generic drug maker Mylan has bought rights to a drug delivery platform made by Pfizer that will allow it to make generic versions of two GlaxoSmithKline respiratory drugs, Mylan said Wednesday.

November 4, 2011

If the ultimate goal of the Affordable Care Act is to save money and expand patient care, then making patients visit their physicians and get prescriptions just to get reimbursed for over-the-counter medications — which wastes money, as well as the time of physicians, a precious commodity when the country is set to have a shortage of them — makes no sense.

November 4, 2011

A bill proposed in Congress would give states incentives for using generic drugs through the Medicaid program.

November 4, 2011

In the classic “Arabian Nights” tale of Aladdin and his magic lamp, the evil sorcerer who made Aladdin retrieve the lamp containing the genie attempts to get it back by tricking Aladdin’s wife into giving it to him by roaming through the streets offering to trade “new lamps for old.”


November 4, 2011

In September, the Generic Pharmaceutical Association announced the appointment of Ralph Neas — former president and CEO of the National Coalition on Health Care — as its new president and CEO, replacing Kathleen Jaeger, who stepped down as president and CEO of the organization in May 2010.

November 4, 2011

In February, Drug Store News discussed three issues concerning generic drugs that would figure prominently throughout the year: drug safety, user fees and patent settlements.


November 3, 2011

The Food and Drug Administration has approved 35 new drugs over the past 12 months, the agency said Thursday.

November 2, 2011

The Food and Drug Administration has approved changes to the labeling of a cancer drug made by Takeda Pharmaceuticals, the drug maker said.

November 2, 2011

Drug maker Perrigo has filed for regulatory approval of a generic topical drug for treating testosterone deficiency, prompting a patent infringement suit from the branded version's manufacturer.

October 31, 2011

Watson Pharmaceuticals and a partnering company are barred from launching a generic version of a blood-thinning drug under a federal court decision issued Friday.

October 31, 2011

President Barack Obama issued an executive order Monday to address the growing problem of drug shortages.

October 28, 2011

Saturday is the Drug Enforcement Administration's National Prescription Drug Take-Back Day, and the country's largest lobbying group representing the generic drug industry is expressing its support.

October 28, 2011

The program to offer certain generic drugs virtually for free to Medicare Part D beneficiaries is one of Rite Aid’s many new ways to attract more customers and thus grow its sales and profits, especially in the pharmacy.

October 25, 2011

The Federal Trade Commission released a report Tuesday finding that drug companies entered 28 deals that the FTC called anticompetitive and said would increase healthcare costs for consumers and the government.

October 25, 2011

Medicare Part D beneficiaries will be able to obtain hundreds of generic drugs without any deductible or co-pay under a new program offered by Rite Aid.